Predictive Model for Postoperative Complications in Hemi-hip Arthroplasty

Sponsor
Seoul National University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03375268
Collaborator
(none)
460
1
92
5

Study Details

Study Description

Brief Summary

The purpose of this study was to identify the major complications and their risk factors of elderly patients who had undergone Hemi-hip Arthroplasty.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    We retrospectively reviewed the medical records and reviewed the major complications and identify risk factors of elderly patients who had undergone Hemi-hip Arthroplasty for adults aged 60 years or older from January 2011 to December 2015.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    460 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Predictive Model for Postoperative Complications in Elderly Patients With Hip Arthroplasty: Retrospective Study
    Actual Study Start Date :
    Jan 1, 2011
    Actual Primary Completion Date :
    Dec 31, 2015
    Anticipated Study Completion Date :
    Aug 31, 2018

    Outcome Measures

    Primary Outcome Measures

    1. postoperative complications [from operation day to postoperative 30 days]

      we collect postoperative complications which include cardiac, pulmonary renal, cerebral, and other complications.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • A patient scheduled to undergo spinal anesthesia for Hemi-hip Arthroplasty
    Exclusion Criteria:
      1. Patients with acute infectious disease before surgery 2) Patients with fractures around the implant 3) Patients who underwent reoperation during hospitalization 4) During the study period, Duplicate patient who underwent the opposite side of the hip during hospitalization

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Eulji university hospital Seoul Korea, Republic of 01830

    Sponsors and Collaborators

    • Seoul National University Hospital

    Investigators

    • Principal Investigator: Eunsu Choi, pf, Eulji University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Seoul National University Hospital
    ClinicalTrials.gov Identifier:
    NCT03375268
    Other Study ID Numbers:
    • 2017-10-003
    First Posted:
    Dec 18, 2017
    Last Update Posted:
    Dec 18, 2017
    Last Verified:
    Dec 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 18, 2017